Search

everythinglearnresearchcommunity

for

Search:↓

Overexpressing NSD3 in mice causes breast cancer-like tumors and gland abnormalities.

M50054 may help treat hepatitis and hair loss from chemotherapy.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Blocking JAK-STAT5 signaling in mice leads to hair growth.

Meis1 is crucial for skin health and tumor development.

Losing both ERBB2 and ERBB3 receptors in mice causes significant skin problems and inflammation.

FERONIA regulates plant growth, pollen interactions, and sugar signaling.

Low-level laser therapy reduces symptoms and inflammation in frontal fibrosing alopecia.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

A peptide from hair follicle stem cells promotes hair growth by activating specific skin cells.

The FOS gene helps hair growth in Tan sheep.

DNMT3A is crucial for healthy skin and hair growth.

A protein made in a plant stopped hair growth in mice.

WNT activation in scalp fibroblasts boosts hair growth by increasing FGF9.

Lymphotoxin-β is crucial for proper skin development in embryos.

Mutations in the TSPEAR gene cause a new form of ectodermal dysplasia affecting hair and tooth development.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

Inhibiting the PI3K/Akt pathway may help prevent radiation-induced liver injury.

Foxn1 gene regulation is crucial for thymus development but not for hair growth.

A new compound shows promise as a topical treatment for hair loss.

FGF12 is important for hair growth and could be targeted for hair loss treatment.

Editing the FGF5 gene in sheep increases wool length, confirming its role in hair growth.

Androgens reduce THY1 in skin cells, leading to less fat, more fibrosis, and worse healing in males.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

MEF2C is crucial for normal hair cycle progression.

Estrogen and MLL enzymes work together to regulate genes important for hair growth and leukemia.